The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Hydroxy-2-phenyl-butyric acid 7-hydroxy-4-oxy-5,6,7,7a-tetrahydro-3H-pyrrolizin-1-ylmethyl ester ID: ALA2115358
PubChem CID: 71456306
Max Phase: Preclinical
Molecular Formula: C18H23NO5
Molecular Weight: 333.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@@](O)(C(=O)OCC1=CC[N+]2([O-])CC[C@@H](O)[C@@H]12)c1ccccc1
Standard InChI: InChI=1S/C18H23NO5/c1-2-18(22,14-6-4-3-5-7-14)17(21)24-12-13-8-10-19(23)11-9-15(20)16(13)19/h3-8,15-16,20,22H,2,9-12H2,1H3/t15-,16-,18+,19?/m1/s1
Standard InChI Key: SJOLWQZOAAVHCY-DXHOFVPLSA-N
Molfile:
RDKit 2D
25 27 0 0 1 0 0 0 0 0999 V2000
6.1941 -11.4541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2227 -10.6290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0134 -10.4056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3340 -8.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5089 -8.7554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4775 -11.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9676 -11.7406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2227 -12.6230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4034 -11.6948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1021 -9.4773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4377 -10.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9392 -11.0072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2884 -9.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0850 -8.0448 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7524 -9.4601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1477 -8.7496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2085 -9.5633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7352 -8.0334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5603 -9.4601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3398 -10.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3168 -7.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7524 -10.8869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9900 -10.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5889 -10.8811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2113 -9.8039 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 10 1 0
6 7 1 0
7 1 1 0
8 1 1 0
9 1 1 0
10 13 1 0
11 2 1 0
12 9 1 0
13 3 1 0
14 5 2 0
15 4 1 0
4 16 1 1
11 17 1 1
18 4 1 0
19 15 1 0
20 15 2 0
21 18 1 0
22 20 1 0
23 19 2 0
24 22 2 0
2 25 1 6
11 12 1 0
6 3 2 0
23 24 1 0
M CHG 2 1 1 8 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.38Molecular Weight (Monoisotopic): 333.1576AlogP: 1.22#Rotatable Bonds: 5Polar Surface Area: 89.82Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.69CX Basic pKa: 2.83CX LogP: 0.22CX LogD: 0.22Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.37Np Likeness Score: 1.63
References 1. Zalkow LH, Glinski JA, Gelbaum LT, Moore D, Melder D, Powis G.. (1988) Semisynthetic pyrrolizidine alkaloid N-oxide antitumor agents. Esters of heliotridine., 31 (8): [PMID:3397989 ] [10.1021/jm00403a008 ]